HLB Pharmaceutical Co., Ltd (047920.KQ)

KRW 23050.0

(-1.5%)

Revenue Summary of HLB Pharmaceutical Co., Ltd

  • HLB Pharmaceutical Co., Ltd's latest annual revenue in 2023 was 135.95 Billion KRW , up 26.49% from previous year.
  • HLB Pharmaceutical Co., Ltd's latest quarterly revenue in 2024 Q2 was 35.77 Billion KRW , up 6.94% from previous quarter.
  • HLB Pharmaceutical Co., Ltd reported a annual revenue of 107.48 Billion KRW in annual revenue 2022, up 71.01% from previous year.
  • HLB Pharmaceutical Co., Ltd reported a annual revenue of 62.85 Billion KRW in annual revenue 2021, up 54.92% from previous year.
  • HLB Pharmaceutical Co., Ltd reported a quarterly revenue of 35.77 Billion KRW for 2024 Q2, up 6.94% from previous quarter.
  • HLB Pharmaceutical Co., Ltd reported a quarterly revenue of 34.63 Billion KRW for 2023 Q3, down -1.62% from previous quarter.

Annual Revenue Chart of HLB Pharmaceutical Co., Ltd (2023 - 2016)

Historical Annual Revenue of HLB Pharmaceutical Co., Ltd (2023 - 2016)

Year Revenue Revenue Growth
2023 135.95 Billion KRW 26.49%
2022 107.48 Billion KRW 71.01%
2021 62.85 Billion KRW 54.92%
2020 40.57 Billion KRW 12.39%
2019 36.09 Billion KRW 75.75%
2018 20.54 Billion KRW 32.03%
2017 15.55 Billion KRW -23.54%
2016 20.34 Billion KRW 0.0%

Peer Revenue Comparison of HLB Pharmaceutical Co., Ltd

Name Revenue Revenue Difference
CMG Pharmaceutical Co., Ltd. 93.9 Billion KRW -44.774%
Celltrion Pharm, Inc. 388.79 Billion KRW 65.032%
Huons Global Co., Ltd. 758.37 Billion KRW 82.073%
DongKook Pharmaceutical Co., Ltd. 730.99 Billion KRW 81.402%
Enzychem Lifesciences Corporation 76.03 Billion KRW -78.794%
Humedix Co., Ltd. 152.27 Billion KRW 10.718%
Boditech Med Inc. 134.21 Billion KRW -1.292%
EuBiologics Co., Ltd. 69.36 Billion KRW -95.994%
FutureChem Co.,Ltd 13.96 Billion KRW -873.315%
Huons Co., Ltd. 552 Billion KRW 75.371%
BNC Korea Co., Ltd. 80.99 Billion KRW -67.848%
AptaBio Therapeutics Inc. 323.86 Million KRW -41877.723%